Participate in a Study to Advance Treatments for Cross-Contact with Gluten
Learn more and see if you qualify. Participate in a Study to Advance Treatments for Cross-Contact with Gluten
Continue ReadingLearn more and see if you qualify. Participate in a Study to Advance Treatments for Cross-Contact with Gluten
Continue ReadingIn recent years, there has been a marked increase in the number of people diagnosed with celiac disease around the world. This pattern suggests that a greater percentage of the…
Continue ReadingNo one likes invasive medical procedures; doctors and researchers are always on the lookout for ways to diagnose celiac disease that avoid intestinal biopsy. This is especially true when it…
Continue ReadingUsing data gathered on children born in Bavaria, Germany between the years 2005-2007, researchers sought to make a connection between gastrointestinal or respiratory infections and the development of celiac disease.…
Continue ReadingClostridium difficile (C.diff) is a widely prevalent bacterium that causes abdominal cramping and diarrhea in affected individuals. In the United States, close to half a million people contract C.diff infection…
Continue ReadingLaunched in February 2016, iCureCeliac® is a free online portal for patients, or their caregivers, to provide critical insights into life with celiac disease and gluten/wheat sensitivity. Anonymized questionnaire data, completed by…
Continue ReadingThe current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous…
Continue ReadingImmusanT, a biotechnology company focusing on protecting patients with celiac disease against the effects of gluten, has announced that it has secured $40 million in funding to advance its drug,…
Continue ReadingIn the August 15, 2017 issue of the esteemed Journal of the American Medical Association, a spotlight was cast on celiac disease and non-celiac gluten sensitivity, with a comprehensive review…
Continue ReadingImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease…
Continue Reading